Biochemical Assessment of Erythropoietin Products From Asia Versus US Epoetin alfa Manufactured by Amgen
Authors:
- 1 May 2009
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 98 (5) , 1688-1699
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- The First Biosimilar EpoetinClinical Journal of the American Society of Nephrology, 2008
- Effects of protein aggregates: An immunologic perspectiveThe AAPS Journal, 2006
- Biosimilars: How similar or dissimilar are they? (Review Article)Nephrology, 2006
- Influence of aggregation on immunogenicity of recombinant human Factor VIII in hemophilia A miceJournal of Pharmaceutical Sciences, 2006
- Structural Characterization and Immunogenicity in Wild-Type and Immune Tolerant Mice of Degraded Recombinant Human Interferon Alpha2bPharmaceutical Research, 2005
- Follow-on biologics: challenges of the ‘next generation’Nephrology Dialysis Transplantation, 2005
- Structure-Immunogenicity Relationships of Therapeutic ProteinsPharmaceutical Research, 2004
- Minimizing the immunogenicity of protein therapeuticsDrug Discovery Today, 2004
- Letter 2: Equivocal role of micelles in Eprex adverse eventsNature Biotechnology, 2003
- Protein Aggregates Seem to Play a Key Role Among the Parameters Influencing the Antigenicity of Interferon Alpha (IFN-α) in Normal and Transgenic MicePharmaceutical Research, 1997